Hillhurst Biopharmaceuticals, Inc.
No bio yet
This person is not in any teams
This person is not in any offices
Hillhurst Biopharmaceuticals, Inc.
Hillhurst’s proprietary GLASS platform enables novel uses of therapeutic gases that, up until now, have been limited by inhaled delivery. We’ve developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson’s disease, and acute pain.